These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 8729368

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [Abstract] [Full Text] [Related]

  • 5. [Can 1/1 atrial flutter be foreseen by class I anti-arrhythmics?].
    Brembilla-Perrot B, Terrier de la Chaise A, Jacquemin L, Beurrier D, Houplon P, Louis P, Danchin N.
    Arch Mal Coeur Vaiss; 1997 Jul; 90(7):961-6. PubMed ID: 9339257
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Broad complex tachycardia during treatment of atrial fibrillation with a 1c antiarrhythmic drug: ventricular or supraventricular proarrhythmia?
    Wiesfeld AC, Ansink JM, van Veldhuisen DJ, van Gelder IC.
    Int J Cardiol; 2006 Feb 08; 107(1):140-1. PubMed ID: 15990183
    [No Abstract] [Full Text] [Related]

  • 9. [Can the supraventricular proarrhythmic effects of class 1C antiarrhythmic drugs be prevented with the association of beta blockers?].
    Brembilla-Perrot B, Houriez P, Claudon O, Yassine M, Suty-Selton C, Vancon AC, Abo el Makarem Y, Makarem E, Courtelour JM.
    Ann Cardiol Angeiol (Paris); 2000 Dec 08; 49(8):439-42; discussion 442-3. PubMed ID: 12555430
    [Abstract] [Full Text] [Related]

  • 10. [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].
    Jastrzebski M.
    Kardiol Pol; 2008 Nov 08; 66(11):1221-4; discussion 1225. PubMed ID: 19105102
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
    Fauchier JP, Rouesnel P, Breuillac JC, Cosnay P, Scheck F, Garnier LF.
    Ann Cardiol Angeiol (Paris); 1994 Apr 08; 43(4):194-203. PubMed ID: 8024234
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Catheter ablation in supraventricular tachycardia].
    Pitschner HF, Neuzner J.
    Z Kardiol; 1996 Apr 08; 85 Suppl 6():45-60. PubMed ID: 9064982
    [Abstract] [Full Text] [Related]

  • 19. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D, Rowland E, O'Nunain S, Shakespeare CF, Poloniecki J, Camm AJ.
    Eur Heart J; 1995 Dec 08; 16(12):1930-5. PubMed ID: 8682029
    [Abstract] [Full Text] [Related]

  • 20. [Efficacy of propafenone in supraventricular arrhythmias].
    Kauffmann R, Goich J, Parra C, Ayala A, Manzur F.
    Rev Med Chil; 1989 Apr 08; 117(4):401-5. PubMed ID: 2519393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.